Brief: Intervacc Says Completed Manufacturing Process For Strangvac

Intervacc AB

25/11/2019 20:32

Nov 25 (Reuters) - Intervacc AB  IVACC.ST :
    * INTERVACC SAYS CO HAS, TOGETHER WITH 3P BIOPHARMACEUTICALS
AND
LIOF-PHARMA, COMPLETED MANUFACTURING PROCESS FOR STRANGVAC
    * VALIDATION PRODUCTION BATCHES REQUIRED FOR FORTHCOMING
REGISTRATION APPLICATION TO EUROPEAN MEDICINES AGENCY, EMA, ARE
FINALIZED
    * IN TOTAL, 60 000 VIALS WITH VACCINE DOSES HAVE BEEN
MANUFACTURED
AND RELEASED

Source text for Eikon:  ID:nWkr4ypwwd 
Further company coverage:  IVACC.ST 

 ((Reuters.Briefs@thomsonreuters.com;))